Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly.

The global Somavert market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Somavert volume and value at global level, regional level and company level. From a global perspective, this report represents overall Somavert market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Somavert in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Somavert manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Prefilled
Non-prefilled

Segment by Application
Hospital
Pharmacy